Impetigo Treatment Market Insights, Global Outlook and Forecast 2022-2028
Impetigo Treatment Market Insights, Global Outlook and Forecast 2022-2028
The research report on ‘Impetigo Treatment Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Impetigo Treatment is typically treated with an antibiotic ointment or cream that apply directly to the sores.
The latest research study released by Market IntelliX evaluates market size and forecasts of Impetigo Treatment in Global, including the following market information:
Global Impetigo Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Impetigo Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cephalosporins Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Impetigo Treatment include GlaxoSmithKline plc, Karalex Pharma, LLC, Leo Pharma A/S, Lupin Limited, NovaBay Pharmaceuticals, Inc., Pfizer, Inc., Ranbaxy Laboratories Limited, Roche Holding AG and SANDOZ GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Impetigo Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Impetigo Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Impetigo Treatment Market Segment Percentages, by Type, 2021 (%)
Cephalosporins
Fusidane
Lincosamide Antibiotic
Penicillin
Penicillin-Like Antibiotics
Pleuromutilin
Pseudomonic Acid A
Quinolone
Sulfonamides And Folic Acid Inhibitors
Tetracyclines
Global Impetigo Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Impetigo Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Impetigo Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Impetigo Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Impetigo Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Impetigo Treatment revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
GlaxoSmithKline plc
Karalex Pharma, LLC
Leo Pharma A/S
Lupin Limited
NovaBay Pharmaceuticals, Inc.
Pfizer, Inc.
Ranbaxy Laboratories Limited
Roche Holding AG
SANDOZ GmbH
Taro Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Impetigo Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Impetigo Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Impetigo Treatment Overall Market Size
2.1 Global Impetigo Treatment Market Size: 2021 VS 2028
2.2 Global Impetigo Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Impetigo Treatment Players in Global Market
3.2 Top Global Impetigo Treatment Companies Ranked by Revenue
3.3 Global Impetigo Treatment Revenue by Companies
3.4 Top 3 and Top 5 Impetigo Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Impetigo Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Impetigo Treatment Players in Global Market
3.6.1 List of Global Tier 1 Impetigo Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Impetigo Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Impetigo Treatment Market Size Markets, 2021 & 2028
4.1.2 Cephalosporins
4.1.3 Fusidane
4.1.4 Lincosamide Antibiotic
4.1.5 Penicillin
4.1.6 Penicillin-Like Antibiotics
4.1.7 Pleuromutilin
4.1.8 Pseudomonic Acid A
4.1.9 Quinolone
4.1.10 Sulfonamides And Folic Acid Inhibitors
4.1.11 Tetracyclines
4.2 By Type - Global Impetigo Treatment Revenue & Forecasts
4.2.1 By Type - Global Impetigo Treatment Revenue, 2017-2022
4.2.2 By Type - Global Impetigo Treatment Revenue, 2023-2028
4.2.3 By Type - Global Impetigo Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Impetigo Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Impetigo Treatment Revenue & Forecasts
5.2.1 By Application - Global Impetigo Treatment Revenue, 2017-2022
5.2.2 By Application - Global Impetigo Treatment Revenue, 2023-2028
5.2.3 By Application - Global Impetigo Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Impetigo Treatment Market Size, 2021 & 2028
6.2 By Region - Global Impetigo Treatment Revenue & Forecasts
6.2.1 By Region - Global Impetigo Treatment Revenue, 2017-2022
6.2.2 By Region - Global Impetigo Treatment Revenue, 2023-2028
6.2.3 By Region - Global Impetigo Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Impetigo Treatment Revenue, 2017-2028
6.3.2 US Impetigo Treatment Market Size, 2017-2028
6.3.3 Canada Impetigo Treatment Market Size, 2017-2028
6.3.4 Mexico Impetigo Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Impetigo Treatment Revenue, 2017-2028
6.4.2 Germany Impetigo Treatment Market Size, 2017-2028
6.4.3 France Impetigo Treatment Market Size, 2017-2028
6.4.4 U.K. Impetigo Treatment Market Size, 2017-2028
6.4.5 Italy Impetigo Treatment Market Size, 2017-2028
6.4.6 Russia Impetigo Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Impetigo Treatment Market Size, 2017-2028
6.4.8 Benelux Impetigo Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Impetigo Treatment Revenue, 2017-2028
6.5.2 China Impetigo Treatment Market Size, 2017-2028
6.5.3 Japan Impetigo Treatment Market Size, 2017-2028
6.5.4 South Korea Impetigo Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Impetigo Treatment Market Size, 2017-2028
6.5.6 India Impetigo Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Impetigo Treatment Revenue, 2017-2028
6.6.2 Brazil Impetigo Treatment Market Size, 2017-2028
6.6.3 Argentina Impetigo Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Impetigo Treatment Revenue, 2017-2028
6.7.2 Turkey Impetigo Treatment Market Size, 2017-2028
6.7.3 Israel Impetigo Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Impetigo Treatment Market Size, 2017-2028
6.7.5 UAE Impetigo Treatment Market Size, 2017-2028
7 Players Profiles
7.1 GlaxoSmithKline plc
7.1.1 GlaxoSmithKline plc Corporate Summary
7.1.2 GlaxoSmithKline plc Business Overview
7.1.3 GlaxoSmithKline plc Impetigo Treatment Major Product Offerings
7.1.4 GlaxoSmithKline plc Impetigo Treatment Revenue in Global Market (2017-2022)
7.1.5 GlaxoSmithKline plc Key News
7.2 Karalex Pharma, LLC
7.2.1 Karalex Pharma, LLC Corporate Summary
7.2.2 Karalex Pharma, LLC Business Overview
7.2.3 Karalex Pharma, LLC Impetigo Treatment Major Product Offerings
7.2.4 Karalex Pharma, LLC Impetigo Treatment Revenue in Global Market (2017-2022)
7.2.5 Karalex Pharma, LLC Key News
7.3 Leo Pharma A/S
7.3.1 Leo Pharma A/S Corporate Summary
7.3.2 Leo Pharma A/S Business Overview
7.3.3 Leo Pharma A/S Impetigo Treatment Major Product Offerings
7.3.4 Leo Pharma A/S Impetigo Treatment Revenue in Global Market (2017-2022)
7.3.5 Leo Pharma A/S Key News
7.4 Lupin Limited
7.4.1 Lupin Limited Corporate Summary
7.4.2 Lupin Limited Business Overview
7.4.3 Lupin Limited Impetigo Treatment Major Product Offerings
7.4.4 Lupin Limited Impetigo Treatment Revenue in Global Market (2017-2022)
7.4.5 Lupin Limited Key News
7.5 NovaBay Pharmaceuticals, Inc.
7.5.1 NovaBay Pharmaceuticals, Inc. Corporate Summary
7.5.2 NovaBay Pharmaceuticals, Inc. Business Overview
7.5.3 NovaBay Pharmaceuticals, Inc. Impetigo Treatment Major Product Offerings
7.5.4 NovaBay Pharmaceuticals, Inc. Impetigo Treatment Revenue in Global Market (2017-2022)
7.5.5 NovaBay Pharmaceuticals, Inc. Key News
7.6 Pfizer, Inc.
7.6.1 Pfizer, Inc. Corporate Summary
7.6.2 Pfizer, Inc. Business Overview
7.6.3 Pfizer, Inc. Impetigo Treatment Major Product Offerings
7.6.4 Pfizer, Inc. Impetigo Treatment Revenue in Global Market (2017-2022)
7.6.5 Pfizer, Inc. Key News
7.7 Ranbaxy Laboratories Limited
7.7.1 Ranbaxy Laboratories Limited Corporate Summary
7.7.2 Ranbaxy Laboratories Limited Business Overview
7.7.3 Ranbaxy Laboratories Limited Impetigo Treatment Major Product Offerings
7.7.4 Ranbaxy Laboratories Limited Impetigo Treatment Revenue in Global Market (2017-2022)
7.7.5 Ranbaxy Laboratories Limited Key News
7.8 Roche Holding AG
7.8.1 Roche Holding AG Corporate Summary
7.8.2 Roche Holding AG Business Overview
7.8.3 Roche Holding AG Impetigo Treatment Major Product Offerings
7.8.4 Roche Holding AG Impetigo Treatment Revenue in Global Market (2017-2022)
7.8.5 Roche Holding AG Key News
7.9 SANDOZ GmbH
7.9.1 SANDOZ GmbH Corporate Summary
7.9.2 SANDOZ GmbH Business Overview
7.9.3 SANDOZ GmbH Impetigo Treatment Major Product Offerings
7.9.4 SANDOZ GmbH Impetigo Treatment Revenue in Global Market (2017-2022)
7.9.5 SANDOZ GmbH Key News
7.10 Taro Pharmaceutical Industries Ltd
7.10.1 Taro Pharmaceutical Industries Ltd Corporate Summary
7.10.2 Taro Pharmaceutical Industries Ltd Business Overview
7.10.3 Taro Pharmaceutical Industries Ltd Impetigo Treatment Major Product Offerings
7.10.4 Taro Pharmaceutical Industries Ltd Impetigo Treatment Revenue in Global Market (2017-2022)
7.10.5 Taro Pharmaceutical Industries Ltd Key News
7.11 Teva Pharmaceutical Industries Ltd
7.11.1 Teva Pharmaceutical Industries Ltd Corporate Summary
7.11.2 Teva Pharmaceutical Industries Ltd Business Overview
7.11.3 Teva Pharmaceutical Industries Ltd Impetigo Treatment Major Product Offerings
7.11.4 Teva Pharmaceutical Industries Ltd Impetigo Treatment Revenue in Global Market (2017-2022)
7.11.5 Teva Pharmaceutical Industries Ltd Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Impetigo Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|